Structural basis of von Willebrand factor biology and physics

冯维勒布兰德因子生物学和物理学的结构基础

基本信息

  • 批准号:
    10434710
  • 负责人:
  • 金额:
    $ 67.37万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-07-01 至 2023-06-30
  • 项目状态:
    已结题

项目摘要

von Willebrand factor (VWF) is a multi-domain plasma protein secreted by endothelial cells. In hemostasis, VWF binds and crosslinks platelets to one another and the vessel wall to form the platelet plug. VWF also binds to and stabilizes factor VIII (FVIII) in the coagulation cascade. VWF mutations cause the most common heritable bleeding disorders called von Willebrand disease (VWD). The D1, D2, and D´D3 assemblies in VWF are specialized domains that enable biosynthesis of VWF into ultralong concatemers that are stored as helical tubules in Weibel-Palade bodies (WPBs). D´D3 also binds FVIII. Long length enables VWF to sense flow. Changes in flow at sites of bleeding activate VWF by 1) elongating coiled VWF concatemers into a thread-like conformation that exposes previously buried A1 domains and 2) activating a high-affinity state of VWF A1 domains that bind platelet glycoprotein Ibα (GPIbα) for platelet plug formation. High-resolution structures of D assemblies and the high-affinity state of A1 are lacking. In Aim 1, we will determine the structure of the high- affinity state of A1. Unfolding studies show that VWF A2 and A3 domains have two states, whereas A1 has three: native, intermediate, and unfolded. Preliminary studies show that truncating the O-glycosylated linkers N- and C-terminal destabilizes the native state of A1 and increases affinity for GPIbα. We propose that the intermediate state corresponds to the high-affinity state of A1. We test the hypothesis that further truncation of the linkers flanking A1, gain-of-function mutations (e.g. activating VWD mutations), and the allosteric activator ristocetin all increase A1 affinity for GPIbα by stabilizing the intermediate state over the native state. We will use combinations of truncations, mutations, and ristocetin to stabilize A1 in the intermediate state and to determine the crystal structure of the putative high-affinity state of A1 and its complex with GPIbα. Aim 2 will determine structures of D´D3 and the D´D3 dimer. Our preliminary crystal structure of the D´D3 monomer shows how the C8, TIL, and E modules pack around the VWD module to form the D3 assembly. D´ protrudes from the D3 assembly. The two cysteines that have been proposed to form the inter-dimer disulfide bonds are buried. We will solve the structure of a D´D3 dimer (D´D3)2 or a D3 dimer with the protruding D´ removed to define the structural rearrangements required for D´D3 dimerization. Proposed disulfide rearrangement that precedes dimerization will be verified by mutation and in vitro reconstitution. As backup, we will pursue a cryo- EM structure of VWF helical tubules to determine the structure of (D´D3)2 and how D assemblies enable formation of highly ordered tubules. Aim 3 uses crystallography to understand how D’D3 binds FVIII, which has the potential through protein engineering to revolutionize replacement FVIII therapy in hemophilia A. As an alternative strategy, we will determine a cryoEM structure of a D’D3 complex with FVIII. Better structural understanding of VWF D assemblies and the high-affinity state of A1 has important therapeutic implications for stroke, thrombosis, VWD, and hemophilia A.
血管性血友病因子(vonWillebrand factor,VWF)是由内皮细胞分泌的多结构域血浆蛋白。在止血方面, VWF结合并交联血小板彼此和血管壁以形成血小板栓。VWF也 在凝血级联中结合并稳定因子VIII(FVIII)。VWF突变导致最常见的 遗传性出血性疾病称为血管性血友病(VWD)。VWF中的D1、D2和D'D3组装体 是使VWF生物合成为超长串联体的专门结构域, 韦伯-帕拉德小体(Webel-Palade body,WPB)D'D3也结合FVIII。长的长度使VWF能够感测流量。 出血部位血流的变化通过以下方式激活VWF:1)将卷曲的VWF多联体延长成线状 暴露先前被掩埋的A1结构域的构象和2)激活VWF A1的高亲和力状态 结合血小板糖蛋白Ib α(GPIb α)形成血小板栓的结构域。D的高分辨率结构 缺乏A1的高亲和力状态。在目标1中,我们将确定高- A1的亲和力状态。解折叠研究表明,VWF A2和A3结构域有两种状态,而A1结构域有两种状态, 三种:天然的、中间的和未折叠的。初步研究表明,截短O-糖基化接头 N末端和C末端使A1的天然状态不稳定,并增加对GPib α的亲和力。我们建议 中间状态对应于A1的高亲和力状态。我们测试的假设,进一步截断 侧接A1的接头、功能获得性突变(例如激活VWD突变)和变构激活剂 Ristoclavin通过稳定中间态而增加A1对GPIb α的亲和力。我们将 使用截短、突变和逆转录酶的组合以使A1稳定在中间状态, 确定A1及其与GPIb α复合物的推定高亲和力状态的晶体结构。目标2将 确定D'D3和D'D3二聚体的结构。我们对D'D3单体的初步晶体结构 显示了C8、TIL和E模块如何围绕VWD模块封装以形成D3组件。D ′突出 从D3组件。已经提出形成二聚体间二硫键的两个半胱氨酸是 埋了我们将解析D ′ D3二聚体(D ′ D3)2或去除突出D ′的D3二聚体的结构, 定义D'D3二聚化所需的结构重排。提出的二硫键重排, 将通过突变和体外重构来验证在二聚化之前发生的突变。作为后援,我们要进行低温- VWF螺旋小管的EM结构,以确定(D ′ D3)2的结构以及D组装如何使 形成高度有序的小管。目的3使用晶体学来了解D'D3如何结合FVIII,其具有 通过蛋白质工程改造血友病A的FVIII替代疗法的潜力。作为 作为替代策略,我们将确定D'D3与FVIII复合物的cryoEM结构。更好的结构 了解VWF D组装和A1的高亲和力状态对治疗具有重要意义, 中风、血栓形成、VWD和血友病A。

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Von Willebrand factor A1 domain stability and affinity for GPIbα are differentially regulated by its O-glycosylated N- and C-linker.
  • DOI:
    10.7554/elife.75760
  • 发表时间:
    2022-05-09
  • 期刊:
  • 影响因子:
    7.7
  • 作者:
    Bonazza, Klaus;Iacob, Roxana E.;Hudson, Nathan E.;Li, Jing;Lu, Chafen;Engen, John R.;Springer, Timothy A.
  • 通讯作者:
    Springer, Timothy A.
Monomeric prefusion structure of an extremophile gamete fusogen and stepwise formation of the postfusion trimeric state.
  • DOI:
    10.1038/s41467-022-31744-z
  • 发表时间:
    2022-07-13
  • 期刊:
  • 影响因子:
    16.6
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TIMOTHY A SPRINGER其他文献

TIMOTHY A SPRINGER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TIMOTHY A SPRINGER', 18)}}的其他基金

Latent TGF-β2 Structure and Activation
潜在 TGF-β2 结构和激活
  • 批准号:
    10586060
  • 财政年份:
    2022
  • 资助金额:
    $ 67.37万
  • 项目类别:
Latent TGF-β2 Structure and Activation
潜在 TGF-β2 结构和激活
  • 批准号:
    10446300
  • 财政年份:
    2022
  • 资助金额:
    $ 67.37万
  • 项目类别:
Structural basis of von Willebrand factor biology and physics
冯维勒布兰德因子生物学和物理学的结构基础
  • 批准号:
    10198035
  • 财政年份:
    2019
  • 资助金额:
    $ 67.37万
  • 项目类别:
Structures and Conformational Equilibria of Integrin alpha5 beta1
整合素α5β1的结构和构象平衡
  • 批准号:
    9079774
  • 财政年份:
    2016
  • 资助金额:
    $ 67.37万
  • 项目类别:
Structures and Conformational Equilibria of Integrin alpha5 beta1
整合素α5β1的结构和构象平衡
  • 批准号:
    9265127
  • 财政年份:
    2016
  • 资助金额:
    $ 67.37万
  • 项目类别:
Structural mechanisms underlying latency and activation of GDF8
GDF8 潜伏期和激活的结构机制
  • 批准号:
    9302311
  • 财政年份:
    2016
  • 资助金额:
    $ 67.37万
  • 项目类别:
Activation trajectories of integrin α5β1
整合素 α5α1 的激活轨迹
  • 批准号:
    10320795
  • 财政年份:
    2016
  • 资助金额:
    $ 67.37万
  • 项目类别:
Activation trajectories of integrin α5β1
整合素 α5α1 的激活轨迹
  • 批准号:
    10545063
  • 财政年份:
    2016
  • 资助金额:
    $ 67.37万
  • 项目类别:
Structural mechanisms underlying latency and activation of GDF8
GDF8 潜伏期和激活的结构机制
  • 批准号:
    9175103
  • 财政年份:
    2016
  • 资助金额:
    $ 67.37万
  • 项目类别:
TGF-beta latency and activation
TGF-β潜伏期和激活
  • 批准号:
    8963063
  • 财政年份:
    2015
  • 资助金额:
    $ 67.37万
  • 项目类别:

相似海外基金

Construction of affinity sensors using high-speed oscillation of nanomaterials
利用纳米材料高速振荡构建亲和传感器
  • 批准号:
    23H01982
  • 财政年份:
    2023
  • 资助金额:
    $ 67.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Affinity evaluation for development of polymer nanocomposites with high thermal conductivity and interfacial molecular design
高导热率聚合物纳米复合材料开发和界面分子设计的亲和力评估
  • 批准号:
    23KJ0116
  • 财政年份:
    2023
  • 资助金额:
    $ 67.37万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Platform for the High Throughput Generation and Validation of Affinity Reagents
用于高通量生成和亲和试剂验证的平台
  • 批准号:
    10598276
  • 财政年份:
    2023
  • 资助金额:
    $ 67.37万
  • 项目类别:
Development of High-Affinity and Selective Ligands as a Pharmacological Tool for the Dopamine D4 Receptor (D4R) Subtype Variants
开发高亲和力和选择性配体作为多巴胺 D4 受体 (D4R) 亚型变体的药理学工具
  • 批准号:
    10682794
  • 财政年份:
    2023
  • 资助金额:
    $ 67.37万
  • 项目类别:
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
  • 批准号:
    2233343
  • 财政年份:
    2023
  • 资助金额:
    $ 67.37万
  • 项目类别:
    Standard Grant
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
  • 批准号:
    2233342
  • 财政年份:
    2023
  • 资助金额:
    $ 67.37万
  • 项目类别:
    Standard Grant
Molecular mechanisms underlying high-affinity and isotype switched antibody responses
高亲和力和同种型转换抗体反应的分子机制
  • 批准号:
    479363
  • 财政年份:
    2023
  • 资助金额:
    $ 67.37万
  • 项目类别:
    Operating Grants
Deconstructed T cell antigen recognition: Separation of affinity from bond lifetime
解构 T 细胞抗原识别:亲和力与键寿命的分离
  • 批准号:
    10681989
  • 财政年份:
    2023
  • 资助金额:
    $ 67.37万
  • 项目类别:
CAREER: Engineered Affinity-Based Biomaterials for Harnessing the Stem Cell Secretome
职业:基于亲和力的工程生物材料用于利用干细胞分泌组
  • 批准号:
    2237240
  • 财政年份:
    2023
  • 资助金额:
    $ 67.37万
  • 项目类别:
    Continuing Grant
ADVANCE Partnership: Leveraging Intersectionality and Engineering Affinity groups in Industrial Engineering and Operations Research (LINEAGE)
ADVANCE 合作伙伴关系:利用工业工程和运筹学 (LINEAGE) 领域的交叉性和工程亲和力团体
  • 批准号:
    2305592
  • 财政年份:
    2023
  • 资助金额:
    $ 67.37万
  • 项目类别:
    Continuing Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了